Cardiovascular Disease Devices Whitepaper
Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases. However, this grouping of lifestyle has also increased the likelihood of cardiovascular disorders. Cardiovascular disorders pose a threat to both the heart and the associated blood vessels, for instance angina, stroke, coronary artery disease, aortic aneurysm amongst several others. There is a tremendous increase in both research and development amongst MedTech giants trying to hoe a tough rope and coming up with breakthrough technologies that can cater to this domain. These technologies comprise of a mix of devices including implantable cardiac monitors and defibrillators, coronary stents, ventricular assist devices, ablation devices, robotic sleeves, 3D-bioprinted heart tissues among others.
The purpose of this whitepaper “Medtronic, Abbott and Boston Scientific: The Big Players in Cardiovascular Industry” is to articulate about the CVD related disorders and the most relevant devices that help in the treatment of patients suffering from them. It majorly focuses on the top three pioneers in the industry, namely Medtronic, Abbott and Boston Scientific that have the best-in-class cardiovascular portfolio in this realm. The whitepaper not only carries a snippet as to what are the most potential factors that seem to promote the CVD industry, but also talks about why exactly are Medtronic, Abbott and Boston Scientific the most renowned names in the CVD arena. It has an extended segment illustrating their biggest mergers and acquisitions across the world and CVD devices that are a part of their current pipeline.
With the help of this whitepaper, DelveInsight provides an insight about the major MedTech companies and their competitive landscape, how exactly is their CVD portfolio contributing in their success and the comparison between their important divisions (devices) in CVD.